LON:HCM - Hutchison China MediTech Share Price, Forecast & News

Hutchison China MediTech trades on the London Stock Exchange (LON) under the ticker symbol "HCM."

Hutchison China MediTech is scheduled to release their next quarterly earnings announcement on Tuesday, March 3rd 2020. View Earnings Estimates for Hutchison China MediTech.

2 Wall Street analysts have issued 12 month target prices for Hutchison China MediTech's stock. Their forecasts range from GBX 360 to GBX 5,940. On average, they anticipate Hutchison China MediTech's stock price to reach GBX 3,150 in the next twelve months. This suggests a possible upside of 691.5% from the stock's current price. View Analyst Price Targets for Hutchison China MediTech.

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Hutchison China MediTech in the last year. There are currently 1 hold rating and 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Hutchison China MediTech.

News headlines about HCM stock have trended very negative recently, InfoTrie reports. The research group scores the sentiment of news coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. Hutchison China MediTech earned a news impact score of -3.3 on InfoTrie's scale. They also gave news articles about the company a news buzz of 10.0 out of 10, indicating that recent news coverage is extremely likely to have an effect on the company's share price in the next few days. View News Stories for Hutchison China MediTech.

Some companies that are related to Hutchison China MediTech include Dechra Pharmaceuticals (DPH), Opthea (OPT), Medical Developments International (MVP), Mayne Pharma Group (MYX), Vectura Group (VEC), BEXIMCO PHARMAC/S GDR REGS (BXP), Eco Animal Health Group (EAH), Trilogy International Partners (TRL), Allergy Therapeutics (AGY), Recce Pharmaceuticals (RCE), NanoViricides (NNVC), Pharmaxis (PXS), Vita Life Sciences (VLS), Futura Medical (FUM) and Avivagen (VIV).

Based on aggregate information from My MarketBeat watchlists, some companies that other Hutchison China MediTech investors own include Intelsat (I), Associated British Foods (ABF), Fossil Group (FOSL), Chaarat Gold (CGH), AMC Entertainment (AMC), Bank of America (BAC), First Data (FDC), Air Canada (AC), tronc (TRNC) and Apollo Global Management (APO).

Shares of HCM and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

One share of HCM stock can currently be purchased for approximately GBX 398.

Hutchison China MediTech has a market capitalization of £2.75 billion and generates £204.65 million in revenue each year. Hutchison China MediTech employs 714 workers across the globe.View Additional Information About Hutchison China MediTech.

The official website for Hutchison China MediTech is http://www.chi-med.com/.

The company can be reached via phone at +85221213888.